Colistimethate Sodium
5 NDCs across 3 manufacturers|5 Generic,0 Brand
Colistimethate Sodium is used to treat escherichia coli infections, klebsiella infections, pseudomonas infections and urinary tract infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Feb 26, 1999.
Colistimethate Sodium is available as 5 NDCs from 3 manufacturers (5 generic, 0 brand), with NADAC prices from $15.49 to $15.49 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
3
competing in market
Price Spread
$15.49 – $15.49
per EA
7d Activity
avg +0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Heritage Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Polymyxin-class Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing COLISTIMETHATE SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COLISTIMETHATE 150 MG VIAL | $15.4867 per EA | — |
COLISTIMETHATE 150 MG VIAL | $15.4867 per EA | — |
COLISTIMETHATE 150 MG VIAL | $15.4867 per EA | — |
COLISTIMETHATE 150 MG VIAL | $15.4867 per EA | — |
COLISTIMETHATE 150 MG VIAL | $15.4867 per EA | — |
Frequently Asked Questions
What is Colistimethate Sodium used to treat?
Colistimethate Sodium is used to treat escherichia coli infections, klebsiella infections, pseudomonas infections and urinary tract infections, per the National Library of Medicine's MED-RT classification.
When did Colistimethate Sodium become available as a generic?
FDA approved the first generic Colistimethate Sodium (ANDA) on Feb 26, 1999.
How many Colistimethate Sodium products are on the market?
The Colistimethate Sodium drug market contains 5 NDCs from 3 manufacturers — 5 generic and 0 brand products.
What is the price range for Colistimethate Sodium?
NADAC reference prices for Colistimethate Sodium range from $15.4867 to $15.4867 per EA.
Which manufacturers make Colistimethate Sodium?
3 manufacturers list Colistimethate Sodium in NADAC. Ranked by number of NDCs, the largest are Heritage Pharmaceuticals Inc. (2), Xellia Pharmaceuticals USA LLC (2), Fresenius Kabi USA, LLC (1).